118 related articles for article (PubMed ID: 35732008)
21. A miR-34a-SIRT6 axis in the squamous cell differentiation network.
Lefort K; Brooks Y; Ostano P; Cario-André M; Calpini V; Guinea-Viniegra J; Albinger-Hegyi A; Hoetzenecker W; Kolfschoten I; Wagner EF; Werner S; Dotto GP
EMBO J; 2013 Aug; 32(16):2248-63. PubMed ID: 23860128
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis.
Chen YL; Liu XL; Li L
BMC Cancer; 2021 Jan; 21(1):63. PubMed ID: 33446130
[TBL] [Abstract][Full Text] [Related]
23. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
Rapti SM; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481
[TBL] [Abstract][Full Text] [Related]
24. Right dominance in the incidence of external auditory canal squamous cell carcinoma in the Japanese population: Does handedness affect carcinogenesis?
Tsunoda A; Sumi T; Terasaki O; Kishimoto S
Laryngoscope Investig Otolaryngol; 2017 Feb; 2(1):19-22. PubMed ID: 28894818
[TBL] [Abstract][Full Text] [Related]
25. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
26. Identification of microRNA expression signature for the diagnosis and prognosis of cervical squamous cell carcinoma.
Bozgeyik E; Tepe NB; Bozdag Z
Pathol Res Pract; 2020 Nov; 216(11):153159. PubMed ID: 32841775
[TBL] [Abstract][Full Text] [Related]
27. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
Jia LF; Gan YH; Yu GY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
29. Parotidectomy in the management of squamous cell carcinoma of the external auditory canal.
Xie B; Wang M; Zhang S; Liu Y
Eur Arch Otorhinolaryngol; 2021 May; 278(5):1355-1364. PubMed ID: 32651676
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
31. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
32. [Diagnosis and treatment of rare malignant tumors in external auditory canal].
Wang F; Wu N; Hou Z; Liu J; Shen W; Han W; Yang S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 29(16):1438-42. PubMed ID: 26665451
[TBL] [Abstract][Full Text] [Related]
33. Expression of miR-34a in basal cell carcinoma patients and its relationship with prognosis.
Hu P; Ma L; Wu Z; Zheng G; Li J
J BUON; 2019; 24(3):1283-1288. PubMed ID: 31424691
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑34a inhibits esophageal squamous cell carcinoma progression by targeting E2F5.
Jiang H; Guo Y; Huang K; Lu R; Peng X; Lin S
J BUON; 2019; 24(6):2514-2522. PubMed ID: 31983127
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-34a suppresses invasion and metastatic in esophageal squamous cell carcinoma by regulating CD44.
Zuo J; Zhu K; Wang Y; Yu Z
Mol Cell Biochem; 2018 Jun; 443(1-2):139-149. PubMed ID: 29094237
[TBL] [Abstract][Full Text] [Related]
36. Carbon ion radiotherapy for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.
Koto M; Hasegawa A; Takagi R; Sasahara G; Ikawa H; Mizoe JE; Jingu K; Tsujii H; Kamada T; Okamoto Y;
Head Neck; 2016 Apr; 38(4):512-6. PubMed ID: 25352333
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin.
Shen Z; Zhan G; Ye D; Ren Y; Cheng L; Wu Z; Guo J
Med Oncol; 2012 Dec; 29(4):2473-80. PubMed ID: 22246523
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of inflammatory response markers for locally advanced squamous cell carcinoma of the external auditory canal and middle ear.
Makita K; Hamamoto Y; Takata N; Ishikawa H; Tsuruoka S; Uwatsu K; Hato N; Kido T
J Radiat Res; 2021 Jul; 62(4):662-668. PubMed ID: 34115873
[TBL] [Abstract][Full Text] [Related]
39. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
